Analystreport

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) had its price target raised by analysts at Needham & Company LLC from $25.00 to $32.00. They now have a "buy" rating o

KalVista Pharmaceuticals, Inc.  (KALV) 
Last kalvista pharmaceuticals, inc. earnings: 3/10 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.kalvista.com